The effect of intrauterine and oral levonorgestrel administration on serum concentrations of sex hormone-binding globulin, insulin and insulin-like growth factor binding protein-1

References

• Barbosa I, Bakos O, Olsson SE, Odlind V Johansson ED. Ovarian function during use of a levonorgestrel-releasing IUD Contraception 1990; 42(1): 51–66.
   Google Scholar
• Barbosa I, Olsson SE, Odlind V Goncalves T, Coutinho E. Ovarian function after seven years’ use of a levonorgestrel IUD. Adv Contracept 1995; 11(2): 85–95.
   Google Scholar
• Jia MC, Zhou LY, Ren S, Dong L, Xiao B. Serum SHBG levels during normal menstrual cycle and after insertion of levonorgestrel-releasing IUD. Adv Contracept 1992; 8(1): 33–40.
   Google Scholar
• Xiao BL, Zhou LY, Zhang XL, Jia MC, Luukkainen T, Allonen H. Pharmacokinetic and pharmacodynamic studies of levonorgestrel-releasing intrauterine device. Contraception 1990; 41(4): 353–62.
   PubMed Web of Science ®Google Scholar
• Landgren BM, Aedo AR, Johannisson E, Cekan SZ. Pharmacokinetic and pharmacodynamic effects of vaginal rings releasing levonorgestrel at a rate of 27 micrograms/24 hours: a pilot study. Contraception 1994; 49(2): 139–50.
   PubMed Web of Science ®Google Scholar
• Makhzangy MN, Wynn V, Lawrence DM. Sex hormone binding globulin capacity as an index of oestrogenicity or androgenicity in women on oral contraceptive steroids. Clin Endocrinol 1979; 10: 39–45.
   Google Scholar
• van Kammen E, Thijssen JHH, Rademaker B, Schwarz F. The influence of hormonal contraceptives on sex hormone binding globulin (SHBG) capacity. Contraception 1975; 11: 53–9.
   PubMed Web of Science ®Google Scholar
• Plymate SR, Matej LA, Jones RE, Friedl KE. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab 1988; 67(3): 460–4.
   PubMed Web of Science ®Google Scholar
• Nestler JE, Powers LP, Matt dW et al. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 1991; 72(1): 83–9.
   Google Scholar
• Weaver JU, Holly JM, Kopelman PG et al. Decreased sex hormone binding globulin (SHBG) and insulin-like growth factor binding protein (IGFBP-1) in extreme obesity. Clin Endocrinol 1990; 33(3): 415–22.
   Google Scholar
• Conover CA, Lee PD, Kanaley JA, Clarkson JT, Jensen MD. Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans. J Clin Endocrinol Metab 1992; 74(6): 1355–60.
   Google Scholar
• Suikkari AM, Koivisto VA, Rutanen EM, Yki-Järvinen H, Karonen SL, Seppälä M. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 1988; 66(2): 266–72.
   Google Scholar
• Suikkari AM, Sane T, Seppälä M, Yki-Järvinen H, Karonen SL, Koivisto VA. Prolonged exercise increases serum insulin-like growth factor-binding protein concentrations. J Clin Endocrinol Metab 1989; 68(1): 141–4.
   Google Scholar
• Batch JA, Baxter RC, Werther G. Abnormal regulation of insulin-like growth factor binding proteins in adolescents with insulin-dependent diabetes. J Clin Endocrinol Metab 1991; 73(5): 964–8.
   Google Scholar
• Brismar K, Gutniak M, Povoa G, Werner S, Hall K. Insulin regulates the 35 kDa IGF binding protein in patients with diabetes mellitus. J Endocrinol Invest 1988; 11(8): 599–602.
   Google Scholar
• Nestler JE, Clore JN, Strauss JFD, Blackard WG. The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans. J Clin Endocrinol Metab 1987; 64(1): 180–4.
   Google Scholar
• Suikkari AM, Koivisto VA, Koistinen R, Seppälä M, Yki-Järvinen H. Dose-response characteristics for suppression of low molecular weight plasma insulin-like growth factorbinding protein by insulin. J Clin Endocrinol Metab 1989; 68(1): 135–40.
   Google Scholar
• Giudice LC, Dsupin BA, Irwin JC. Steroid and peptide regulation of insulin-like growth factor-binding proteins secreted by human endometrial stromal cells is dependent on stromal differentiation. J Clin Endocrinol Metab 1992; 75(5): 1235–41.
   Google Scholar
• Julkunen M, Koistinen R, Aalto-Setälä K, Seppälä M, Jänne OA, Kontula K. Primary structure of human insulinlike growth factor-binding protein/placental protein 12 and tissue-specific expression of its mRNA. FEBS Lett 1988; 236(2): 295–302.
   Google Scholar
• Pekonen F, Nyman T, Lähteenmäki P, Haukkamaa M, Rutanen EM. Intrauterine progestin induces continuous insulin-like growth factor-binding protein-1 production in the human endometrium. J Clin Endocrinol Metab 1992; 75(2): 660–4.
   Google Scholar
• Rutanen EM, Salmi A, Nyman T. mRNA expression of insulin-like growth factor-I (IGF-I) is suppressed and those of IGF-II and IGF-binding protein-1 are constantly expressed in the endometrium during use of an intrauterine levonorgestrel system. Mol Hum Reprod 1997; 3(9): 749–54.
   Google Scholar
• Weiner E, Johansson EDB. Plasma levels of d-norgestrel, estradiol and progestreone during treatment with silastic implants containing d-norgestrel. Contraception 1976; 14: 81.
   PubMed Web of Science ®Google Scholar
• Rutanen E-M, Kärkkäinen TH, Lehtovirta J, Uotila JT, Hinkula MK, Hartikainen A-L. Evaluation of a rapid strip test for insulin-like growth factor binding protein-1 in the diagnosis of ruptured fetal membranes. Clin Chim Acta 1996; 253: 91–101.
   PubMed Web of Science ®Google Scholar
• Rutanen EM, Kärkkäinen T, Lundqvist C et al. Monoclonal antibodies to the 27–34K insulin-like growth factor binding protein. Biochem Biophys Res Commun 1988; 152(1): 208–15.
   Google Scholar
• Victor A, Weiner T, Johansson EDB. Sex hormone binding globulin: the carrier protein for d-Norgestrel. J Clin Endocrinol Metab 1976; 43: 244–7.
   Google Scholar
• Pasquali R, Venturoli S, Paradisi R, Capelli M, Parenti M, Melchionda N. Insulin and C-peptide levels in obese patients with polycystic ovaries. Horm Metab Res 1982; 14(6): 284–7.
   Google Scholar
• Pasquali R, Antenucci D, Casimirri F et al. Insulin as a factor of increased androgen production in women with obesity and polycystic ovaries. J Endocrinol Invest 1987; 10(6): 575–9.
   Google Scholar
• Godsland IF, Walton C, Felton C, Proudler A, Patel A, Wynn V. Insulin resistance, secretion, and metabolism in users of oral contraceptives. J Clin Endocrinol Metab 1992; 74(1): 64–70.
   PubMed Web of Science ®Google Scholar
• Preziosi P, Barrett-Connor E, Papoz L et al. Interrelation between plasma sex hormone-binding globulin and plasma insulin in healthy adult women: the Telecom study. J Clin Endocrinol Metab 1993; 76(2): 283–7.
   Google Scholar
• Nilsson CG, Lähteenmäki P, Luukkainen T. Patterns of ovulation and bleeding with a low levonorgestrel-releasing intrauterine device. Contraception 1980; 21(2): 155–64.
   PubMed Web of Science ®Google Scholar
• Nilsson CG, Lähteenmäki PL, Luukkainen T. Ovarian function in amenorrheic and menstruating users of a lev-onorgestrel-releasing intrauterine device. Fertil Steril 1984; 41(1): 52–5.
   Google Scholar